Clinical trial
Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell…
NCT00458653 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00458653 |
|---|---|
| Title | Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma |
| Official title | Vaccination With Dendritic Cell/Tumor Fusions in Conjunction With Autologous Stem Cell Transplant in Patients With Multiple Myeloma |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | Massachusetts General Hospital Dana-Farber Cancer Institute Brigham and Women's Hospital Rambam Health Care Campus |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Biological |
| Interventions | Dendritic Cell Tumor Fusion |
| Enrollment | 45 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2012 |
| Completion | Jul 1, 2020 |
| First posted | Apr 11, 2007 |
| Last update posted | Jun 22, 2023 |
| Countries | Israel, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: